The store will not work correctly when cookies are disabled.
(3-chloropyrazolo[1,5-a]pyridin-2-yl)(4-(2,4-difluorophenethyl)piperazin-1-yl)methanone
ID: ALA1957802
PubChem CID: 57394859
Max Phase: Preclinical
Molecular Formula: C20H19ClF2N4O
Molecular Weight: 404.85
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(c1nn2ccccc2c1Cl)N1CCN(CCc2ccc(F)cc2F)CC1
Standard InChI: InChI=1S/C20H19ClF2N4O/c21-18-17-3-1-2-7-27(17)24-19(18)20(28)26-11-9-25(10-12-26)8-6-14-4-5-15(22)13-16(14)23/h1-5,7,13H,6,8-12H2
Standard InChI Key: HSSOKZQOZIZVNW-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
-1.9252 -2.3627 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.9252 -3.1878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2131 -3.5961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5010 -3.1878 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5010 -2.3627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2131 -1.9460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6410 -1.9523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6434 -1.1272 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.3542 -2.3669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2129 -3.6014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9281 -3.1899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6420 -3.6035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6379 -4.4265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3509 -4.8400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0671 -4.4284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0656 -3.5990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3519 -3.1893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3491 -2.3642 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.7816 -4.8411 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.1129 -2.0318 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.4420 -3.1859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2485 -3.3600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6601 -2.6475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.4809 -2.6486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.8914 -3.3614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4748 -4.0747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6553 -4.0701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8286 -3.7378 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13 14 1 0
1 7 1 0
14 15 2 0
1 2 1 0
15 16 1 0
7 8 2 0
16 17 2 0
17 12 1 0
1 6 1 0
17 18 1 0
7 9 1 0
15 19 1 0
9 20 2 0
2 3 1 0
4 10 1 0
20 23 1 0
22 21 2 0
21 9 1 0
3 4 1 0
10 11 1 0
22 23 1 0
4 5 1 0
23 24 1 0
11 12 1 0
24 25 2 0
5 6 1 0
25 26 1 0
12 13 2 0
26 27 2 0
27 22 1 0
21 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 404.85 | Molecular Weight (Monoisotopic): 404.1215 | AlogP: 3.27 | #Rotatable Bonds: 4 |
Polar Surface Area: 40.85 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.07 | CX LogP: 3.94 | CX LogD: 3.92 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.67 | Np Likeness Score: -2.18 |
References
1. Xiong Y, Ullman B, Choi JS, Cherrier M, Strah-Pleynet S, Decaire M, Feichtinger K, Frazer JM, Yoon WH, Whelan K, Sanabria EK, Grottick AJ, Al-Shamma H, Semple G.. (2012) Identification of fused bicyclic heterocycles as potent and selective 5-HT(2A) receptor antagonists for the treatment of insomnia., 22 (5): [PMID:22325948] [10.1016/j.bmcl.2012.01.080] |